Mako Adoption Helps Drive Stryker to 8.1% Growth in 2Q19
Stryker reports 2Q19 revenue of USD $1,916.7MM, +8.1% vs. 2Q18. Jul 29, 2019
Momentum for Zimmer Biomet Knee Franchise in 2Q19
Zimmer Biomet reports 2Q19 revenue of USD $1,769.4MM, -1.4% vs. 2Q18. Jul 29, 2019
The Spine Market: A Look at Past and Forecasted Performance
Spine is the largest individual segment that we track, accounting for 18.2% of the orthopedic industry's overall revenue. Excluding biologics, sales of orthopedic spine products topped $9.3 billion in 2018, growing +2.7% vs. 2017. Growth in the segment exceeded our expectations, as several companies in the top 10 posted double-digit increases that offset lower performance by manufacturers at the top of the list. Here, we take a deeper look at past, present and forecasted performance. Jul 25, 2019
Integra LifeSciences Reports 2Q19 Orthopedic Revenue of $21.8MM, -1.2% vs. 2Q18
Integra LifeSciences reports 2Q19 orthopedic revenue of USD $21.8MM, -1.2% vs. 2Q18. Jul 25, 2019
Anika Therapeutics Reports 2Q19 Orthobiologic Revenue of $26.5MM, +1% vs. 2Q18
Anika Therapeutics posts 2Q19 orthobiologic revenue of USD $26.5MM, +1% vs. 2Q18. Jul 25, 2019
Episurf Reports 2Q19 Revenue of SEK 1.1MM (USD $0.1MM), +37.5% vs. 2Q18
Episurf reports 2Q19 revenue of SEK 1.1MM (USD $0.1MM), +37.5% vs. 2Q18. Jul 19, 2019
DePuy Synthes Reports 2Q19 Revenue of $2,230.9MM, -1.3% vs. 2Q18
DePuy Synthes reports 2Q19 orthopedic revenue of USD $2,230.9MM, -1.3% vs. 2Q18. Jul 17, 2019
Implanet reports 2Q19 revenue of €1.9MM (USD $2.2MM), +8.4% vs. 2Q18
Implanet reports 2Q19 revenue of €1.9MM (USD $2.2MM), +8.4% vs. 2Q18, with 1H19 revenue of €3.8MM (USD $8.0MM), +5.2% vs. 1H18. Jul 12, 2019
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies covered in this article had combined total orthopedic sales of $8.7 billion, growing just 1.1% versus the prior year. While the top two players, DePuy Synthes and Zimmer Biomet, both saw -2% growth, the quarter did feature strong performances by Medtronic (+5%) and Wright Medical (+16%) among the larger players. Jun 18, 2019
Robotics Recap: Orthopedic Executives Remain Bullish
The first quarter of 2019 was an active one for robotic and digital surgery developments. As adoption of digital surgery tools increases, leadership from joint replacement and spine companies indicate they have seen a direct sales benefit from upselling and product pull through. Jun 15, 2019
